Earningsreport

Q1/2025 3/31/2025 EPS -0.580 ZacksConsensus -0.310 ActVsEst (0.270) - Miss

Relmada Therapeutics, Inc.  (RLMD) 
NASDAQ:AMEX Investor Relations: ir.relmada.com